Seniors will need to consider whether the Medicare Bridge program is right for them, as it’s set to expire next year — and ...

Does Medicare pay for GLP-1 drugs like Ozempic for weight loss? For years, the answer has been a hard no. But a new “Bridge” program upgrades the answer to something more like “yes, but …” For the ...

Millions of Americans are expected to gain coverage for GLP-1 drugs for weight loss under a new U.S. pilot launching on Wednesday in its Medicare program for people aged 65 and older or with ...

GoodRx reports that Medicare's new GLP-1 Bridge program allows eligible Part D enrollees to access weight-loss medications for a $50 copay, starting July 1, 2026.

For the first time ever, Medicare will cover drugs like Wegovy and Zepbound. But a strict BMI checklist and a 2027 deadline have some experts expressing concern.

Starting Wednesday, the federal government is offering a selection of the brand name medications to certain Medicare and ...

The proportion of adults in the US taking GLP-1 medications for weight loss has reached a record high of about 40 million people.

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

Millions of people could meet criteria to receive GLP-1s, which could cost Medicare billions of dollars, according to a ...

Medicare's new GLP-1 coverage could expand access to weight-loss drugs, making ETFs a diversified way to tap growth across the obesity treatment market.

Demand for weight loss drugs is ballooning across the U.S. — and Amazon wants in. The Seattle-based tech giant launched its own GLP-1 program Tuesday aimed at streamlining access to weight loss drugs, ...